Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests: Creation of the Variant Task Force Genotyping Assay - POCTRN

Center news

null Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests: Creation of the Variant Task Force Genotyping Assay

Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests

On February 25, 2022, The RADx initiative created a Variant Task Force (VTF) to assess the impact of emerging SARS-CoV-2 variants on diagnostic testing.

The NIH’s RADx initiative created a Variant Task Force (VTF) in January 2021 to assess the impact of emerging SARS-CoV-2 variants on in vitro diagnostic testing. In July 2021, the RADx VTF initiated an effort to develop a SARS-CoV-2 Polymerase Chain Reaction assay for variant agnostic detection of SARS-CoV-2, as well as early detection and monitoring of SARS-CoV-2 variants.

The aims of this project were to:

Identify SARS-CoV-2 markers useful for the detection of SARS-CoV-2 positive samples across all variants
Develop a panel of SNP markers that can be used to accurately assign lineages to SARS-CoV-2 positive samples
Implement a genotyping approach for the early detection of new and re-emerging variants that signals when markers need to be updated.

Speakers

Richard S. Creager, PhD
RADx Team Leader

Eric Lai, PhD
RADx Team Leader

When:

February 15, 2022, 2PM ET

Watch the webinar >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx